Meridiano

Add Article

No Image Available

Article Details

Title

Article: Insilico Medicine advances Middle East push with UAE AI drug discovery deal

Impact Score

5 / 10

AI Summary (Processed Content)

Insilico Medicine, a Hong Kong-listed biotech firm, saw its shares surge after announcing a partnership with the United Arab Emirates to use AI tools for drug discovery. The deal was finalized in Dubai just weeks before regional military tensions escalated, involving strikes on Iran and retaliatory attacks near the UAE.

Despite this geopolitical instability, UAE officials stated the collaboration will proceed, aiming to expand the use of advanced AI platforms to analyze biological and chemical data for pharmaceutical research.

The main topics covered are a business deal in AI-driven drug discovery, its positive market impact, and the contrasting backdrop of regional military conflict.

Original URL

https://www.scmp.com/business/china-business/article/3345614/insilico-medicine-advances-middle-east-push-uae-ai-drug-discovery-deal?utm_source=rss_feed

Source Feed

Tech - South China Morning Post

Published Date

2026-03-05 22:30

Fetched Date

2026-03-05 19:30

Processed Date

2026-03-05 19:31

Embedding Status

Present

Cluster ID

Not Clustered

Raw Extracted Content

Insilico Medicine advances Middle East push with UAE AI drug discovery deal
Hong Kong-listed biotech firm’s shares jump after announcing partnership to use AI tools in drug discovery in the United Arab Emirates
Shares of Insilico rose as much as 12.8 per cent in morning trading on Thursday before paring gains to close 8.6 per cent higher at HK$56.10. The advance outpaced the benchmark Hang Seng Index, which edged up 0.3 per cent.
The agreement was reached during the World Health Expo in Dubai between February 9 and 12, about two weeks before the United States and Israel launched joint military strikes on Iran on February 28.
Those strikes triggered retaliatory missile and drone attacks targeting cities hosting US military assets across the Gulf, including Dubai and Abu Dhabi. The Hang Seng Index has fallen about 5 per cent since the escalation, ending Thursday at 25,321.
Despite the regional tensions, Shaikha Al Mazrouei, director of the Reference National Laboratory Drug Department at the Emirates Drug Establishment, said the partnership would expand the use of advanced AI tools in pharmaceutical research.
“The collaboration will enable the use of advanced AI platforms based on generative models and reinforcement learning algorithms to analyse biological, chemical and clinical data,” she said in a statement.